This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

Should we deliver autism and ADHD diagnostic services through a “neurodevelopmental pathway”? Findings from the realist evaluation of autism service delivery (RE-ASCaD)

This event took place on Thursday 19 October 2023
Your certificate will be available in your account once you have watched the on-demand video.

Agenda

Should we deliver autism and ADHD diagnostic services through a "neurodevelopmental pathway"? Findings from the realist evaluation of autism service delivery (RE-ASCaD), Dr Ian Male, Consultant Community Paediatrician and Director of Research, Sussex community NHS Foundation Trust; Honorary Senior Lecturer Brighton and Sussex Medical School; Workforce Officer British Association of Community Child Health
Dr Ian Male
Dr Ian Male
Consultant Community Paediatrician and Director of Research, Sussex community NHS Foundation Trust; Honorary Senior Lecturer Brighton and Sussex Medical School; Workforce Officer British Association of Community Child Health

Dr Male is a Consultant Community Paediatrician and leads the local clinic and child development team. He has been working with Trust and local commissioners to develop a potential neurodevelopmental pathway. He leads the realist evaluation of autism service delivery funded by and working with the NHSE autism team. His research interests also include how we can use digitech to aid diagnosis and therapeutic intervention, for example using the Wii Fit in children with cerebral palsy, and access to sport for children with special needs.

What will the webinar cover?

Key learning objectives

  • To explore the findings of a single neurodevelopmental pathway for ASD or ADHD.